Business News • PR NewsWire • Small Molecule Anti-virals with Optimized Efficacy and Fewer Side Effects Fuel Growth in the Hepatitis C Therapeutics Market in Indonesia, Finds Frost & Sullivan

Small Molecule Anti-virals with Optimized Efficacy and Fewer Side Effects Fuel Growth in the Hepatitis C Therapeutics Market in Indonesia, Finds Frost & Sullivan

Small Molecule Anti-virals with Optimized Efficacy and Fewer Side Effects Fuel Growth in the Hepatitis C Therapeutics Market in Indonesia, Finds Frost & Sullivan

SINGAPORE, June 24 /PRNewswire/ -- Regular blood screening conducted in hospitals for at-risk patients, particularly injecting drug users (IDUs), has expanded the patient base and enhanced prospects for the hepatitis C therapeutics market in Indonesia. Moreover, increasing health awareness in Indone

View More : http://www.prnewswire.com/news-releases/small-molecule-anti-virals-with-optimized-efficacy-and-fewer-side-effects-fuel-g...

Releted News by prnewswire

Caterpillar, Wacker Neuson SE Announce Strategic Alliance

Friends Provident CEO (UK) Ltd Interviewed On Potential Acquisition